Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx - 14 Year Stock Price History | BLRX

Historical daily share price chart and data for BioLineRx since 2011 adjusted for splits and dividends. The latest closing stock price for BioLineRx as of August 29, 2025 is 3.79.
  • The all-time high BioLineRx stock closing price was 3354.00 on July 25, 2011.
  • The BioLineRx 52-week high stock price is 26.80, which is 607.1% above the current share price.
  • The BioLineRx 52-week low stock price is 2.30, which is 39.3% below the current share price.
  • The average BioLineRx stock price for the last 52 weeks is 8.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
BioLineRx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.9251 10.2240 10.9520 2.4300 3.7900 -55.72%
2024 29.5721 61.2000 62.2000 7.8080 8.5600 -86.37%
2023 52.7734 26.0000 98.0000 22.5120 62.8000 166.10%
2022 52.9454 83.2000 87.2000 22.6480 23.6000 -71.08%
2021 115.1000 98.0000 195.2000 79.2000 81.6000 -19.05%
2020 77.6543 93.6000 144.8000 44.4000 100.8000 12.00%
2019 187.9434 300.0000 440.4600 78.8000 90.0000 -65.70%
2018 543.2278 660.0000 870.0000 260.9400 262.3800 -59.88%
2017 609.2000 562.7400 783.0000 487.8000 654.0000 18.48%
2016 584.6663 780.0000 780.0000 450.0000 552.0000 -29.23%
2015 1089.1428 1026.0000 1704.0000 738.0010 780.0000 -19.75%
2014 1204.3704 1740.0000 1842.0000 738.0010 972.0000 -42.35%
2013 1465.2072 1590.0000 2850.0000 948.0010 1686.0000 11.07%
2012 1697.3059 1893.6000 3330.0000 1338.0000 1518.0000 -20.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.304B 27.81
Zoetis (ZTS) United States $68.600B 24.89
Takeda Pharmaceutical (TAK) Japan $47.633B 9.72
Daiichi Sankyo, - (DSNKY) Japan $46.412B 23.79
BeOne Medicines - (ONC) Switzerland $32.657B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.720B 0.00
Summit Therapeutics (SMMT) United States $18.140B 0.00
Merck (MKKGY) Germany $16.327B 10.62
Shionogi (SGIOY) Japan $14.836B 14.86
United Therapeutics (UTHR) United States $13.859B 11.99
Neurocrine Biosciences (NBIX) United States $13.780B 41.11
IPSEN (IPSEY) France $11.603B 0.00
Orion OYJ (ORINY) Finland $11.203B 27.00
Madrigal Pharmaceuticals (MDGL) United States $9.707B 0.00
Eisai (ESAIY) $9.076B 10.24
Corcept Therapeutics (CORT) United States $7.332B 61.58
Stevanato Group S.p.A (STVN) Italy $7.105B 41.89
Ionis Pharmaceuticals (IONS) United States $6.793B 0.00
Grifols, S.A (GRFS) Spain $6.786B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.636B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.999B 14.25
Crinetics Pharmaceuticals (CRNX) United States $2.886B 0.00
Hypermarcas (HYPMY) Brazil $2.831B 21.29
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.697B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.494B 8.35
Centessa Pharmaceuticals (CNTA) United Kingdom $2.218B 0.00
Ocular Therapeutix (OCUL) United States $2.178B 0.00
Dyne Therapeutics (DYN) United States $1.956B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.778B 0.00
Guardian Pharmacy Services (GRDN) United States $1.656B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.537B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.420B 0.00
Xeris Biopharma Holdings (XERS) United States $1.276B 0.00
ARS Pharmaceuticals (SPRY) United States $1.271B 0.00
Evotec AG (EVO) Germany $1.246B 0.00
Collegium Pharmaceutical (COLL) United States $1.208B 6.60
Enliven Therapeutics (ELVN) United States $1.206B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.840B 0.00
Akebia Therapeutics (AKBA) United States $0.830B 0.00
ProKidney (PROK) United States $0.736B 0.00
Elite Pharmaceuticals (ELTP) United States $0.705B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.705B 7.27
Theravance Biopharma (TBPH) United States $0.704B 58.21
KalVista Pharmaceuticals (KALV) United States $0.680B 0.00
Organogenesis (ORGO) United States $0.650B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Bioventus (BVS) United States $0.599B 14.50
Tourmaline Bio (TRML) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.588B 7.27
Xencor (XNCR) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.573B 11.75
Oruka Therapeutics (ORKA) United States $0.572B 0.00
Savara (SVRA) United States $0.565B 0.00
Nektar Therapeutics (NKTR) United States $0.558B 0.00
Zevra Therapeutics (ZVRA) United States $0.522B 0.00
Esperion Therapeutics (ESPR) United States $0.446B 0.00
Nanobiotix S.A (NBTX) France $0.443B 0.00
Aquestive Therapeutics (AQST) United States $0.382B 0.00
Aldeyra Therapeutics (ALDX) United States $0.351B 0.00
Altimmune (ALT) United States $0.327B 0.00
Larimar Therapeutics (LRMR) United States $0.324B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.99
4D Molecular Therapeutics (FDMT) United States $0.289B 0.00
AleAnna (ANNA) United States $0.281B 0.00
Galectin Therapeutics (GALT) United States $0.272B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.270B 0.00
Lexeo Therapeutics (LXEO) United States $0.257B 0.00
Korro Bio (KRRO) United States $0.222B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
OmniAb (OABI) United States $0.201B 0.00
Aclaris Therapeutics (ACRS) United States $0.199B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.171B 0.00
China SXT Pharmaceuticals (SXTC) China $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.117B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Wellgistics Health (WGRX) United States $0.113B 0.00
Surrozen (SRZN) United States $0.100B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.091B 20.69
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.067B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.55
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Ainos (AIMD) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
TNF Pharmaceuticals (TNFA) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Indivior (INDV) United States $0.000B 13.42
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.61
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00